Publication | Closed Access

Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo

Liver FibrosisImmune RegulationImmunologyPathologyCholangiopathiesSchisantherin ANf-κb PathwaysCirrhosisInflammationHepatotoxicityHepatology FibrosisCell SignalingFibrosisLiver PhysiologyHepatology InflammationCell BiologyHepatologyLiver DiseaseLiverMedicine